DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Sampson JH, Archer GE, Mitchell DA. , et al.
An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme.
Mol Cancer Ther 2009;
8 (10) 2773-2779
We do not assume any responsibility for the contents of the web pages of other providers.